Miller Edward
SEC CIK 1619252 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | GC | 6,517 | — | $64.0K | 31 | 2022-01-18 | 2025-02-21 |
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Miller Edward made no open-market trades at KLRS in the last 12 months.
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | 2025-02-21 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $10.08 | -106 | 6,517 | -2% | -$1,068 | |
| M | 2025-01-27 | 2025-01-23 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $9.50 | -52 | 6,623 | -0.8% | -$493.85 |
| 2025-01-13 | 2025-01-10 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.44 | -409 | 153.5K | -0.3% | -$179.96 | |
| I | 2024-12-11 | 2024-12-11 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | G - Gift | $0.00 | +57.5K | 346.3K | +20% | $0 |
| 2024-12-11 | 2024-12-11 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | G - Gift | $0.00 | -57.5K | 153.9K | -27% | $0 | |
| 2024-11-20 | 2024-11-19 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.55 | -432 | 211.5K | -0.2% | -$237.60 | |
| 2024-11-06 | 2024-11-05 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.86 | -2,272 | 211.9K | -1% | -$1,954 | |
| M | 2024-10-23 | 2024-10-21+ | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.7745 | -1,401 | 214.2K | -0.6% | -$1,085 |
| 2024-10-04 | 2024-10-03 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.81 | -377 | 215.6K | -0.2% | -$305.37 | |
| 2024-08-20 | 2024-08-19 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.76 | -422 | 216.0K | -0.2% | -$320.72 | |
| 2024-08-07 | 2024-08-05 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.73 | -2,323 | 216.4K | -1% | -$1,696 | |
| M | 2024-07-23 | 2024-07-19+ | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.7446 | -1,391 | 219.5K | -0.6% | -$1,036 |
| 2024-07-03 | 2024-07-02 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.72 | -379 | 220.1K | -0.2% | -$272.88 | |
| 2024-05-21 | 2024-05-17 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.75 | -420 | 220.5K | -0.2% | -$315 | |
| 2024-05-07 | 2024-05-03 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.8 | -2,311 | 220.9K | -1% | -$1,849 | |
| M | 2024-04-23 | 2024-04-19+ | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.75 | -1,383 | 224.0K | -0.6% | -$1,037 |
| 2024-04-04 | 2024-04-02 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.77 | -368 | 224.6K | -0.2% | -$283.36 | |
| 2024-02-22 | 2024-02-20 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.7 | -385 | 225.0K | -0.2% | -$269.50 | |
| 2024-02-06 | 2024-02-05 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.67 | -8,869 | 225.4K | -4% | -$5,942 | |
| 2024-01-25 | 2024-01-23 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.67 | -1,302 | 234.2K | -0.6% | -$872.34 | |
| 2024-01-08 | 2024-01-04 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $0.64 | -424 | 235.5K | -0.2% | -$271.36 | |
| D | 2023-02-03 | 2023-02-02 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | A - Grant | $0.00 | +87.5K | 236.0K | +59% | $0 |
| I | 2023-01-23 | 2022-12-02 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | G - Gift | $0.00 | +98.3K | 288.8K | +52% | $0 |
| 2023-01-23 | 2022-12-02 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | G - Gift | $0.00 | -98.3K | 151.0K | -39% | $0 | |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $5.09 | -2,573 | 148.5K | -2% | -$13.1K |
| I | 2022-11-16 | 2022-11-14 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $8.91 | -2,358 | 190.5K | -1% | -$21.0K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $9.36 | -553 | 249.4K | -0.2% | -$5,176 |
| 2022-10-24 | 2022-10-19 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | S - Sale | $9.36 | -553 | 249.4K | -0.2% | -$5,176 | |
| 2022-08-17 | 2022-08-16 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | A - Grant | $0.00 | +15.0K | 249.9K | +6% | $0 | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | A - Grant | $0.00 | +14.0K | 234.9K | +6% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | Kalaris Therapeutics, Inc. | Miller Edward | GC | A - Grant | $0.00 | +23.3K | 217.3K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations